Picture of Inogen logo

INGN — Inogen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Inogen Inc expected to post a loss of 62 cents a share - Earnings Preview

* Inogen Inc  INGN.OQ   INGN.O  is expected to show a fall
in
quarterly revenue when it reports  results on February 27 for
the period ending December 31 2023
    * The Goleta California-based  company is expected to report
a
12.6% decrease in revenue to $76.987 million from $88.09 million
a year ago, according to the mean estimate from 4 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Inogen Inc is for a loss
of 62
cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Inogen Inc
is
$6.50​, below​ its last closing price of $9.19. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.45       -0.49      -0.55     Missed  -11.7
 Jun. 30 2023  -0.61       -0.59      -0.42     Beat    29.3
 Mar. 31 2023  -0.82       -0.78      -0.88     Missed  -12.8​
 Dec. 31 2022  -0.56       -0.57      -0.20     Beat    65.2
 ​​Sep.        -0.42       -0.42      -0.42     Met     -0.2
 30 2022                                                
 Jun. 30 2022  -0.37       -0.37      -0.15     Beat    59.5​
 Mar. 31 2022  -0.52       -0.51      -0.62     Missed  -21.8
 Dec. 31 2021  -0.72       -0.73      -1.01     Missed  -38.6
 This summary was machine generated February 24 at 02:23 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Inogen

See all news